Exact Mass: 504.1443346
Exact Mass Matches: 504.1443346
Found 83 metabolites which its exact mass value is equals to given mass value 504.1443346
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Clindamycin phosphate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic Same as: D01073
Diacetylchitobiose-6-phosphate
A disaccharide phosphate that is diacetylchitobiose substituted at position 6 by a phospho group.
6-Caffeoylsucrose
6-Caffeoylsucrose is found in herbs and spices. 6-Caffeoylsucrose is a constituent of Salvia officinalis (sage) Constituent of Salvia officinalis (sage). 6-Caffeoylsucrose is found in tea and herbs and spices.
Clindamycin phosphate
4-Ac,1,2,3-tribenzoyl-alpha-D-Pyranose-Arabinose|alpha-D-Pyranose-Arabinose
beta-D-glucopyranosyl 4-O-beta-D-glucopyranosylcaffeate
2E-O-caffeoyl-beta-D-fructofuranosyl-(2->1)-alpha-D-glucopyranoside
6-O-(E)-caffeoyl-(2-O-beta-D-glucopyranosyl)-alpha-D-glucopyranose|6-O-(E)-caffeoyl-2-O-beta-D-glucopyranosyl-alpha-D-glucopyranose
7-hydroxy-5-methoxyphthalide 7-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|everlastoside H
Cys Asp His Met
Cys Asp Met His
Cys His Asp Met
Cys His Met Asp
Cys Met Asp His
Cys Met His Asp
Asp Cys His Met
Asp Cys Met His
Asp His Cys Met
Asp His Met Cys
Asp Met Cys His
Asp Met His Cys
His Cys Asp Met
His Cys Met Asp
His Asp Cys Met
His Asp Met Cys
His Met Cys Asp
His Met Asp Cys
Met Cys Asp His
Met Cys His Asp
Met Asp Cys His
Met Asp His Cys
Met His Cys Asp
Met His Asp Cys
6-Caffeoylsucrose
[(2R,3R,4R)-5-acetyloxy-3,4-dibenzoyloxyoxolan-2-yl]methyl benzoate
N-{2-[(5-chloro-2-{[2-methoxy-4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}methanesulfonamide
C22H25ClN6O4S (504.13464400000004)
(3S,4S,5S)-3-amino-4-hydroxy-6-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-6-oxo-5-phosphonooxyhexanoic acid
C20H29N2O11P (504.15088940000004)
3-[(2-methoxyphenyl)-prop-2-enylsulfamoyl]benzoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester
2-[4-[(E)-2-(6,8-dichloro-2-phenyl-2H-chromen-3-yl)ethenyl]phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
[4-[5,7-Dihydroxy-8-(3-methylbut-2-enyl)-4-oxo-2,3-dihydrochromen-3-yl]-2-hydroxy-6-(3-methylbut-2-enyl)phenyl] hydrogen sulate
RSK4-IN-1 (TFA)
RSK4-IN-1 TFA is a potent RSK4 inhibitor with a IC50 value of 9.5 nM. RSK4-IN-1 TFA has antitumor activity[1].
Vofopitant (dihydrochloride)
C21H25Cl2F3N6O (504.14188959999996)
Vofopitant dihydrochloride (GR 205171A) is a potent, selective and orally available tachykinin neurokinin 1(NK1) receptor antagonist, inhibits [3H]SP binding to the NK1 receptor with pKi values of 9.5 and 10.6 in rat and human membranes respectively, acts as a potential broad-spectrum anti-emetic agent[1].
3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one
5-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3h-2-benzofuran-1-one
3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
1-o-(3'-o-β-d-glucopyranosyl)-(e)-caffeoyl-β-d-glucopyranose
{"Ingredient_id": "HBIN002837","Ingredient_name": "1-o-(3'-o-\u03b2-d-glucopyranosyl)-(e)-caffeoyl-\u03b2-d-glucopyranose","Alias": "NA","Ingredient_formula": "C21H28O14","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OC2C(C(C(C(O2)CO)O)O)O)OC3C(C(C(C(O3)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8611","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-O-(E)-caffeoyl-β-D-gentiobiose
{"Ingredient_id": "HBIN002901","Ingredient_name": "1-O-(E)-caffeoyl-\u03b2-D-gentiobiose","Alias": "NA","Ingredient_formula": "C21H28O14","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "36112","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-o-(e)-caffeoyl-β-gentiobiose
{"Ingredient_id": "HBIN002902","Ingredient_name": "1-o-(e)-caffeoyl-\u03b2-gentiobiose","Alias": "NA","Ingredient_formula": "C21H28O14","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2905","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
[(2r,3s,4s,5r,6s)-3,4,6-trihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
5,11,13,17,19-pentahydroxy-15,22-dioxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1(14),2,4(9),5,7,12,16,18,20-nonaene-6-carboxylic acid
(1s,2s,3r,9r,10s)-3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e)-3-(4-hydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)prop-2-enoate
(1s,2s,3r,9r,10s,17s)-3,9-bis(3,4-dihydroxyphenyl)-2,13,15-trihydroxy-4-oxatetracyclo[8.6.1.0⁵,¹⁷.0¹¹,¹⁶]heptadeca-5,11,13,15-tetraen-7-one
[(2r,3s,4s,5r,6r)-6-{[(2s,3s,4r,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
3-amino-4-hydroxy-5-{[1-(8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)-3-methylbutyl]-c-hydroxycarbonimidoyl}-5-(phosphonooxy)pentanoic acid
C20H29N2O11P (504.15088940000004)